Rishon Laboratories Private Limited - Due diligence report
A 360° intelligence report on Rishon Laboratories Private Limited: trust score, financial health, credit view, compliance, directors, growth…
- Unlock all financial figures & 5-year trends
- Full trust, health & credit-risk scores
- Director details, charges & MCA documents
- One credit unlocks this full due-diligence report
- Use across any company’s report, anytime
- Credits valid for 12 months
Rishon Laboratories Private Limited — 360° Intelligence Report
Generated from MCA filings & public recordsRishon Laboratories Private Limited is assessed as Low Risk with a Trust Score of 75/100. Rishon Laboratories Private Limited is an active private limited indian non-government company incorporated in 2009, operating in the Pharma sector. The company has shown revenue growth across its recent filed years. It was profitable in its latest filed year. Based on MCA filings and public records, it currently shows a low compliance risk and moderate financial risk profile.
Report generated on 22 Nov 2026 from the latest processed filings. Rishon Laboratories Private Limited snapshot & full profile →
Automated indicators derived from public MCA / GST / EPFO records - not a credit rating, not investment, legal or financial advice. Spotted an inaccuracy? Report an error.
Score Card
Higher is safer · rule-based & explainableFinancial Intelligence Dashboard
Standalone · 0 filed year(s)Unlock the full 5-year financial dashboard with charts and year-wise figures.
Get full accessScores and observations on this page are already computed from the real filings - only the underlying figures are locked.
Credit & Compliance Intelligence
Why the scores are what they are- Liabilities ≈ 38% EBITDA - stretched.
- Open charges exceed net worth - secured lenders rank ahead.
- Elevated gearing (D/E 1.42).
- Working-capital cover adequate.
- Profitable - internal accruals available.
- Externally credit-rated (A4).
Charges position: 2 open ( 48.0 cr ) · 5 satisfied ( 12.5 cr ).
| Lender | Charges | Amount |
|---|---|---|
| Hdfc Bank Limited | 1 | 48.0 cr |
| Others | 1 | 48.0 cr |
| Canara Bank | 3 | 48.0 cr |
| State Bank Of India | 1 | 48.0 cr |
| Axis Bank Limited | 1 | 48.0 cr |
- Company status is Active as per MCA.
- Last balance sheet is for Mar 2024 - filings overdue.
- 1 active GST registration(s).
Director Intelligence
Stability score: 95/100| Name | DIN / PAN | Designation | Appointed | Tenure | DIN status |
|---|---|---|---|---|---|
| KAMARAJU NARENDRA KUMAR | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| PATHAPATI VENKATA SATYANARAYANA RAJU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| SATISH KUMAR RAJU PATHAPATI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| LAKSHMI VARA RALLAPALLI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| VINAYAKAKALIKA ANJANEYA RAJU NADIMPALLI | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
| KAKARLAPUDI VENKATA SUBBA RAJU | 01234567 | Director | 01/04/2018 | 6 yrs | Approved |
- 6 directors on the board.
- No disqualified or deactivated DINs.
- Stable board - no exits in 3 years.
- Average tenure above 5 years.
| Name | Designation | Total remuneration |
|---|---|---|
| A K Sharma | Managing Director | 2.4 cr |
| R Mehta | Whole-time Director | 1.6 cr |
| S Iyer | CFO | 95.0 L |
Remuneration is disclosed in the latest annual return. Unlock full report
Ownership & Group Intelligence
As per FY 2023 annual returnPromoters hold a dominant controlling stake - exact percentages are part of the full report.
Full shareholding pattern, group structure & capital events →
Risk Intelligence Center
Growth 80 · Distress 55Stakeholder Verdicts
Vendor · Banker · Investor- Statutory record is clean.
- 3 distress signal(s) - see Risk Center.
- Financial filings available for verification.
- Debt capacity assessed from filed statements.
- 2 open charge(s) already registered.
- Compliance record supports lending.
- 3 growth signal(s) detected.
- Margin and return trends computable from filings.
- Management team looks stable.
MCA Filings & Events Timeline
Latest 15 eventsKey Observations
Auto-generated from the data above| Company | CIN | Location |
|---|---|---|
| Samrat Remedies India Private Limited | U24100MH1985PTC035969 | Mumbai, Maharashtra, India |
| Gensynth Laboratories Private Limited | U24230TG2004PTC044953 | Patancheru, Telangana, India |
| Suryakalalabs | U24231TG2001PTC038120 | Serilingampally, Telangana, India |
| The Standard Chemical Company Private Limited | U24232TN1936PTC062365 | Chennai, Tamil Nadu, India |
| Synpol Products Private Limited | U24299GJ1973PTC002440 | Ahmedabad, Gujarat, India |
| Dhanraj Organic Pvt Ltd | U24119MP1994PTC008699 | Indore, Madhya Pradesh, India |
| Vannsh | U24100TG2014PTC094869 | Hyderabad, Telangana, India |
| Sinterx Pharma Private Limited | U24299TG2021PTC154397 | Seri Lingampally, Telangana, India |
Who Uses This Report
CA · CS · Banker · Investor · VendorVerify Rishon Laboratories Private Limited before audits and certifications: compliance score 75/100, filing history, auditor history and charge records in one place - instead of pulling each MCA form separately.
Track statutory health of Rishon Laboratories Private Limited: ACTIVE compliance status, annual-return recency, director DIN status, board churn and the events timeline - the inputs for secretarial audits and due-diligence certificates.
Current banker verdict: Mixed indicators - deeper appraisal suggested. Credit risk score 40/100, existing charge position and lender relationships - a first-pass credit memo before formal appraisal.
Investor view: Positive growth indicators. Growth score 80/100, margin trends, ownership structure and peer set for Rishon Laboratories Private Limited - screening before a deeper diligence.
Vendor verdict: Review suggested. Trust score 75/100, distress signals and MSME payment-delay disclosures - know whether Rishon Laboratories Private Limited pays its suppliers before you extend credit terms.
Litigation footprint (no cases on record), regulatory flags, charge documents trail and director networks for Rishon Laboratories Private Limited - groundwork for KYC, onboarding and disputes.
Frequently Asked Questions
Is Rishon Laboratories Private Limited an active company?
Rishon Laboratories Private Limited has MCA status “Active” with a compliance score of 75/100 (Low Risk).
Is Rishon Laboratories Private Limited financially healthy?
Rishon Laboratories Private Limited has a Financial Health Score of 60/100 (Moderate) based on its filed financial statements.
Should I do business with Rishon Laboratories Private Limited?
Its overall Trust Score is 75/100 (Low Risk). Vendor verdict: Review suggested. Review the risk flags in the Risk Intelligence Center before deciding.
Who controls Rishon Laboratories Private Limited?
Promoters hold a dominant controlling stake - exact percentages are in the full report. 6 active director(s) are on record.
Does Rishon Laboratories Private Limited have loans or charges against its assets?
2 open charge(s) are registered against its assets, and 5 earlier charge(s) stand satisfied.
Is Rishon Laboratories Private Limited up to date with its ROC filings?
Last balance sheet is for Mar 2024 - filings overdue. Overall compliance score: 75/100 (Low Risk).
Is it risky to lend to Rishon Laboratories Private Limited?
Its Credit Risk Score is 40/100 (Caution Indicated). Banker verdict: Mixed indicators - deeper appraisal suggested.